MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $723 | +460.5% | 219,846 | +601.4% | 0.03% | +416.7% |
| Q1 2023 | $129 | -62.5% | 31,346 | -46.6% | 0.01% | -68.4% |
| Q4 2022 | $344 | -99.9% | 58,658 | 0.0% | 0.02% | -20.8% |
| Q3 2022 | $397,000 | +154.5% | 58,658 | +133.7% | 0.02% | +26.3% |
| Q4 2021 | $156,000 | -7.7% | 25,102 | +40.3% | 0.02% | -13.6% |
| Q3 2021 | $169,000 | -31.9% | 17,892 | +92.1% | 0.02% | -69.0% |
| Q4 2020 | $248,000 | -68.9% | 9,312 | -72.7% | 0.07% | -73.8% |
| Q2 2020 | $797,000 | +226.6% | 34,061 | -18.7% | 0.27% | +163.1% |
| Q1 2020 | $244,000 | -18.1% | 41,881 | -19.5% | 0.10% | +15.7% |
| Q4 2019 | $298,000 | +388.5% | 52,031 | +34.3% | 0.09% | +287.0% |
| Q3 2019 | $61,000 | -61.1% | 38,731 | 0.0% | 0.02% | -60.3% |
| Q2 2019 | $157,000 | +42.7% | 38,731 | +85.0% | 0.06% | -7.9% |
| Q1 2019 | $110,000 | – | 20,933 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |